The University of Kansas Cancer Center - Overland Park — Overland Park, Kansas

The University of Kansas Cancer Center - Overland Park is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center - Overland Park has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Triple Negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer.

Sponsors: University of Kansas Medical Center, Dana-Farber Cancer Institute, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Overland Park

Browse all research sites in Kansas · View every site in Overland Park

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center - Overland Park?

The University of Kansas Cancer Center - Overland Park has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center - Overland Park conducted?

The University of Kansas Cancer Center - Overland Park has 7 clinical trials on record, with 6 currently active. Their work covers Triple Negative Breast Cancer, Breast Cancer, Metastatic Breast Cancer.

Is The University of Kansas Cancer Center - Overland Park accredited by Crixeo Clinical Trials?

The University of Kansas Cancer Center - Overland Park has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center - Overland Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.